ES2285227T3 - Arilbenzodiazepinas sustituidas con piperazina. - Google Patents

Arilbenzodiazepinas sustituidas con piperazina. Download PDF

Info

Publication number
ES2285227T3
ES2285227T3 ES03784411T ES03784411T ES2285227T3 ES 2285227 T3 ES2285227 T3 ES 2285227T3 ES 03784411 T ES03784411 T ES 03784411T ES 03784411 T ES03784411 T ES 03784411T ES 2285227 T3 ES2285227 T3 ES 2285227T3
Authority
ES
Spain
Prior art keywords
alkyl
sup
quad
sub
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03784411T
Other languages
English (en)
Spanish (es)
Inventor
Thomas Daniel Aicher
Zhaogen Chen
Yvan Le Huerou
Fionna Mitchell Eli Lilly and Company Ltd. MARTIN
Marta Maria Pineiro-Nunez
Vincent Patrick Rocco
Kevin Michael Ruley
John Mehnert Schaus
Patrick Gianpietro Spinazze
David Edward Eli Lilly and Company TUPPER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2285227T3 publication Critical patent/ES2285227T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES03784411T 2002-08-05 2003-07-28 Arilbenzodiazepinas sustituidas con piperazina. Expired - Lifetime ES2285227T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40129702P 2002-08-05 2002-08-05
US401297P 2002-08-05

Publications (1)

Publication Number Publication Date
ES2285227T3 true ES2285227T3 (es) 2007-11-16

Family

ID=31715704

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03784411T Expired - Lifetime ES2285227T3 (es) 2002-08-05 2003-07-28 Arilbenzodiazepinas sustituidas con piperazina.

Country Status (10)

Country Link
US (1) US7384934B2 (pt)
EP (1) EP1546134B1 (pt)
AT (1) ATE361289T1 (pt)
AU (1) AU2003264915A1 (pt)
CY (1) CY1110382T1 (pt)
DE (1) DE60313634T2 (pt)
DK (1) DK1546134T3 (pt)
ES (1) ES2285227T3 (pt)
PT (1) PT1546134E (pt)
WO (1) WO2004014895A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE327744T1 (de) 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
ATE228358T1 (de) 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh Neue verwendung einer klasse von peptidverbindungen zur behandlung von allodynie oder andere arten von chronischen oder phantomschmerzen
EP1664063A1 (en) * 2003-09-09 2006-06-07 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
AR048272A1 (es) * 2004-03-18 2006-04-12 Lek Pharmaceuticals Sintesis de 2 metil - 4- (4- metil -1- piperazinil) - 10 h- tieno ( 2,3-b) (1,5) benzodiazepina y sus sales, metodos para su preparacion, composiciones farmaceuticas que la contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mentales.
ATE471717T1 (de) 2004-08-27 2010-07-15 Ucb Pharma Gmbh Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
EP1642889A1 (en) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
MY147756A (en) 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
SI2462990T1 (sl) 2006-06-15 2014-04-30 Ucb Pharma Gmbh Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom
MX2009009535A (es) 2007-03-15 2009-09-16 Aryx Therapeutics Inc Compuestos de dibenzo[b,f][1,4]oxazapina.
CN101925587B (zh) * 2008-01-31 2013-05-01 费米有限公司 喹硫平的制备方法
PL395468A1 (pl) * 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
PL2888373T3 (pl) 2012-08-21 2018-08-31 Janssen Pharmaceutica Nv Przeciwciała dla arypiprazolu i ich zastosowanie
TR201816378T4 (tr) * 2012-08-21 2018-11-21 Janssen Pharmaceutica Nv Olanzapin haptenleri.
ES2807902T3 (es) 2012-08-21 2021-02-24 Janssen Pharmaceutica Nv Anticuerpos para olanzapina y uso de los mismos
TR201910347T4 (tr) 2012-08-21 2019-07-22 Janssen Pharmaceutica Nv Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı.
JP6286429B2 (ja) 2012-08-21 2018-02-28 ヤンセン ファーマシューティカ エヌ．ベー． パリペリドンのハプテン
WO2014031645A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone haptens and use thereof
PT2888257T (pt) 2012-08-21 2017-11-14 Janssen Pharmaceutica Nv Haptenos de quetiapina para utilização em ensaios imunológicos
PL3663317T3 (pl) 2012-08-21 2023-06-05 Janssen Pharmaceutica Nv Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
AU2013305938B2 (en) 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to paliperidone haptens and use thereof
EP3933406A3 (en) 2012-08-21 2022-04-20 Janssen Pharmaceutica NV Antibodies to risperidone and use thereof
US9012648B2 (en) 2012-08-21 2015-04-21 Janssen Pharmaceutica Nv Haptens of risperidone and paliperidone
WO2014031668A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to quetiapine and use thereof
CN110054694B (zh) 2012-08-21 2024-02-20 詹森药业有限公司 阿立哌唑半抗原的抗体及其用途
US9504682B2 (en) 2012-08-21 2016-11-29 Janssen Pharmaceutica Nv Haptens of aripiprazole
WO2014031630A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to paliperidone and use thereof
JP6289479B2 (ja) 2012-10-15 2018-03-07 アルベマール・コーポレーシヨン ２−アミノ−４，６−ジメトキシベンズアミド及び他のベンズアミド化合物の合成方法
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
RU2610169C2 (ru) 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" ПРОИЗВОДНЫЕ 7-ФТОРО-8-ХЛОРО-5Н-ДИБЕНЗО[b, е][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ
CN104530077A (zh) * 2014-12-29 2015-04-22 杭州师范大学 一种奥氮平中间体的合成方法
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
CN108368180B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 喹硫平的抗体及其用途
MA44056A (fr) 2015-12-17 2018-10-24 Janssen Pharmaceutica Nv Anticorps anti-rispéridone et leur utilisation
CN110452183B (zh) * 2019-09-04 2023-03-14 中国科学院上海有机化学研究所 一种手性杂环化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB8819059D0 (en) 1988-08-11 1988-09-14 Lilly Industries Ltd Benzodiazepine compounds & their use as pharmaceuticals
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
JP3156933B2 (ja) 1997-09-02 2001-04-16 ウェルファイド株式会社 縮合チオフェン化合物およびその医薬用途
JP2005533009A (ja) * 2002-03-28 2005-11-04 イーライ・リリー・アンド・カンパニー ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用

Also Published As

Publication number Publication date
DE60313634D1 (de) 2007-06-14
AU2003264915A1 (en) 2004-02-25
PT1546134E (pt) 2007-08-10
US7384934B2 (en) 2008-06-10
WO2004014895A1 (en) 2004-02-19
CY1110382T1 (el) 2015-04-29
DK1546134T3 (da) 2007-09-10
EP1546134A1 (en) 2005-06-29
EP1546134B1 (en) 2007-05-02
DE60313634T2 (de) 2008-01-31
US20060084643A1 (en) 2006-04-20
ATE361289T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
ES2285227T3 (es) Arilbenzodiazepinas sustituidas con piperazina.
ES2297142T3 (es) Arilbenzodiazepinas sustituidas con piperazina y su uso como antagonistas del receptor de dopamina para el tratamiento de trastornos psicoticos.
DE60132235T2 (de) Tetrahydrobenzazepin-derivate zur verwendung als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
ES2371053T3 (es) Compuestos de benzazepina que tienen afinidad por el receptor d3 de dopamina y usos de los mismos.
ES2392796T3 (es) Moduladores de tipo indol del receptor nicotínico de acetilcolina alfa-7
ES2234657T3 (es) Inhibidores triciclicos de poli(adp-ribosa)polimerasas.
JP5097696B2 (ja) Ｖｒ１拮抗剤としての２，３−置換縮合ピリミジン−４（３ｈ）−オン
AU2005299032B2 (en) Imidazo-benzodiazepine derivatives
CN102827167A (zh) 八氢-吡咯并[3,4-b]吡咯衍生物及其作为组胺-3 受体配体的用途
PT97776A (pt) Processo para a preparacao de derivados de azol e de composicoes farmaceuticas que os contem
WO2004074291A1 (en) Triazole compounds useful in therapy
JP2010519226A (ja) ５−ｈｔ６受容体親和性を有する６’位置換インドール及びインダゾール誘導体
WO2006051410A1 (en) Azabenzoxazoles for the treatment of cns disorders
ES2332051T3 (es) Compuestos y procedimientos para tratar dislipidemia.
EP1664063A1 (en) Substituted piperazines of azepines, oxazepines, and thiazepines
ES2333918T3 (es) Derivados de pirrolidina que tiene la actividad en el transportador glyt1.
ES2674476T3 (es) Derivados de pirroloquinolina como antagonistas de 5-HT6, método de preparación y uso de los mismos
IE922342A1 (en) Imidazo[2,1-b]benzothiazole-3-acetamide derivatives, their¹preparation and their use in therapeutics
CA1321996C (en) Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
NZ250679A (en) 2-phenyl-9h-imidazo[1,2-a] benzimidazole-3-acetamide derivatives; their preparation and pharmaceutical compositions
EP1597260A1 (en) Triazole compounds useful in therapy
JP2008504332A (ja) ドーパミンｄ３受容体に対してアフィニティーを有する化合物およびその医薬における使用
PT1534391E (pt) Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
BRPI0813777B1 (pt) composto, composição farmacêutica, e, uso de um composto
ES2365687T3 (es) Tiazoliopirimidinas y su utilización como inhibidores de la fosfatidilinositol-3-quinasa.